Company filings profile · CIK 0001610820
BriaCell Therapeutics Corp. — SEC filings & insider activity.
Real, source-linked SEC EDGAR activity for BriaCell Therapeutics Corp. (BCTX): 1 filings in the last 90 days vs 4 in the prior 90 (filing-velocity cooling ↓ · 0.25×). Latest material 8-K events, insider Form-4 transactions, and periodic reports — monitored for change.
✔ Verified against the public SEC EDGAR filing record as of Nov 4, 2026. Source-linked, daily-refreshed.
Material 8-K events — BriaCell Therapeutics Corp.
8-K disclosures decoded by item code (the material events: agreements, results, control/management changes, impairments, restatements).
| Filed | Event | |
|---|---|---|
| Jun 26, 2026 | Regulation FD Disclosure; Financial Statements and Exhibits | ↗ |
| Jun 3, 2026 | Entry into a Material Agreement; Unregistered Sale of Securities; Other Events; Financial Statements and Exhibits | ↗ |
| Mar 31, 2026 | Regulation FD Disclosure; Financial Statements and Exhibits | ↗ |
| Mar 9, 2026 | Item 5.07 | ↗ |
| Feb 20, 2026 | Other Events; Financial Statements and Exhibits | ↗ |
| Jan 15, 2026 | Entry into a Material Agreement; Other Events; Financial Statements and Exhibits | ↗ |
| Dec 29, 2025 | Regulation FD Disclosure; Financial Statements and Exhibits | ↗ |
| Dec 1, 2025 | Regulation FD Disclosure; Financial Statements and Exhibits | ↗ |
| Aug 26, 2025 | Other Events; Financial Statements and Exhibits | ↗ |
| Jul 16, 2025 | Entry into a Material Agreement; Other Events; Financial Statements and Exhibits | ↗ |
Watch BriaCell Therapeutics Corp. automatically
Add this company to a watchlist and get a webhook/email the moment it files a material 8-K, an insider Form 4, or changes its risk-factor language.
Insider transactions (Form 4 / 3 / 5)
| Filed | Form | |
|---|---|---|
| No insider filings in the current window. | ||
Recent filings
| Filed | Form | Detail | |
|---|---|---|---|
| Oct 28, 2026 | 10-K | 10-K | ↗ |
| Jun 26, 2026 | 8-K | Regulation FD Disclosure; Financial Statements and Exhibits | ↗ |
| Jun 9, 2026 | 10-Q | 10-Q | ↗ |
| Jun 3, 2026 | 8-K | Entry into a Material Agreement; Unregistered Sale of Securities; Other Events; Financial Statements and Exhibits | ↗ |
| Jun 2, 2026 | 424B5 | 424B5 | ↗ |
| Mar 31, 2026 | 8-K | Regulation FD Disclosure; Financial Statements and Exhibits | ↗ |
| Mar 10, 2026 | 10-Q | 10-Q | ↗ |
| Mar 9, 2026 | 8-K | Item 5.07 | ↗ |
| Feb 26, 2026 | 25-NSE | ↗ | |
| Feb 20, 2026 | 8-K | Other Events; Financial Statements and Exhibits | ↗ |
| Feb 12, 2026 | DEF 14A | DEF 14A | ↗ |
| Jan 23, 2026 | SCHEDULE 13G | ↗ | |
| Jan 15, 2026 | 8-K | Entry into a Material Agreement; Other Events; Financial Statements and Exhibits | ↗ |
| Jan 14, 2026 | 424B4 | 424B4 | ↗ |
| Jan 13, 2026 | EFFECT | Item ; Item ; Item | ↗ |
| Jan 13, 2026 | S-1MEF | S-1MEF | ↗ |
| Jan 13, 2026 | CERT | ↗ | |
| Jan 13, 2026 | 8-A12B | 8-A12B | ↗ |
| Jan 8, 2026 | CORRESP | ↗ | |
| Jan 8, 2026 | CORRESP | ↗ | |
| Jan 6, 2026 | CORRESP | ↗ | |
| Jan 6, 2026 | CORRESP | ↗ | |
| Dec 29, 2025 | 8-K | Regulation FD Disclosure; Financial Statements and Exhibits | ↗ |
| Dec 23, 2025 | FWP | FWP | ↗ |
| Dec 23, 2025 | S-1 | S-1 | ↗ |
| Dec 11, 2025 | 10-Q | 10-Q | ↗ |
| Dec 1, 2025 | 8-K | Regulation FD Disclosure; Financial Statements and Exhibits | ↗ |
| Nov 7, 2025 | SCHEDULE 13G/A | ↗ | |
| Oct 16, 2025 | DRSLTR | ↗ | |
| Oct 16, 2025 | DRS | ↗ | |
| Oct 16, 2025 | 10-K | 10-K | ↗ |
| Oct 10, 2025 | SCHEDULE 13G | ↗ | |
| Aug 26, 2025 | 8-K | Other Events; Financial Statements and Exhibits | ↗ |
| Aug 1, 2025 | S-8 | S-8 | ↗ |
| Jul 28, 2025 | SCHEDULE 13G | ↗ | |
| Jul 22, 2025 | SCHEDULE 13G | ↗ | |
| Jul 21, 2025 | SCHEDULE 13G/A | ↗ | |
| Jul 16, 2025 | 8-K | Entry into a Material Agreement; Other Events; Financial Statements and Exhibits | ↗ |
| Jul 16, 2025 | 424B4 | 424B4 | ↗ |
| Jul 15, 2025 | EFFECT | Item ; Item ; Item | ↗ |